Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Lidocaine Hydrochloride Injection
Status: Currently in Shortage
»Date first posted:
02/22/2012
»Therapeutic Categories: Anesthesia; Pediatric
Afaxys Pharma (Reverified 04/08/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Injection, 10 mg/1 mL (NDC 50102-400-10) | Available | Inventory available through ANDA, ASD Healthcare, Henry Schein, McKesson Medical-Surgical and R&S |
Amphastar Pharmaceuticals, Inc. (Reverified 04/24/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1) | Available | old NDC 0548-3390-00 |
Baxter Healthcare (Reverified 04/17/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03) | Available | ||
Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02) | Available |
Eugia US LLC (Reverified 04/22/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Lidocaine Hydrochloride Preservative Free, Injection, 10 mg/mL (NDC 55150-158-72) | Unavailable | Intermittent availability expected | Demand increase for the drug |
Lidocaine Hydrochloride Preservative Free, Injection, 10 mg/1 mL (NDC 55150-159-74) | Unavailable | Intermittent availability expected | Demand increase for the drug |
Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 55150-160-72) | Unavailable | Intermittent availability expected | Demand increase for the drug |
Lidocaine Hydrochloride Preservative Free, Injection, 10 mg/1 mL (NDC 55150-161-02) | Available | Check wholesalers for inventory | |
Lidocaine Hydrochloride Preservative Free, Injection, 10 mg/1 mL (NDC 55150-162-05) | Available | Check wholesalers for inventory | |
Lidocaine Hydrochloride Preservative Free, Injection, 10 mg/1 mL (NDC 55150-163-30) | Available | Check wholesalers for inventory | |
Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/mL (NDC 55150-164-02) | Available | Check wholesalers for inventory | |
Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 55150-165-05) | Available | Intermittent availability expected | |
Injection, 10 mg/mL (NDC 55150-251-10) | Available | Check wholesalers for inventory | |
Injection, 10 mg/mL (NDC 55150-252-20) | Available | Check wholesalers for inventory | |
Injection, 20 mg/mL (NDC 55150-254-10) | Available | Check wholesalers for inventory | |
Injection, 20 mg/mL (NDC 55150-255-20) | Available | Check wholesalers for inventory | |
Injection, 20 mg/mL (NDC 55150-256-50) | Available | Check wholesalers for inventory |
Fresenius Kabi USA, LLC (Reverified 04/16/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97) | Unavailable | Next release not available at this time. | Demand increase for the drug |
Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91) | Unavailable | Next release not available at this time. | Demand increase for the drug |
Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02) | Available | ||
Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05) | Available | ||
Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17) | Available | ||
Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27) | Available | ||
Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57) | Available | ||
Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27) | Available | ||
Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07) | Available | ||
Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97) | Unavailable | Next release date not available at this time. | Demand increase for the drug |
Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57) | Unavailable | Next release not available at this time. | Demand increase for the drug |
Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57) | Available | ||
Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02) | Available | ||
Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10) | Available | ||
Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27) | Available | ||
Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57) | Available | ||
Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27) | Available | ||
Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57) | Available | ||
Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37) | Available | ||
Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31) | Unavailable | Next release not available at this time. | Demand increase for the drug |
Hikma Pharmaceuticals USA, Inc. (Reverified 04/23/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Lidocaine HCl Injection, USP Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25) | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
Lidocaine HCl Injection, USP Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25) | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
Lidocaine HCl Injection, USP, Injection, 10 mg/1 mL (NDC 0143-9577-10) | Unavailable | Additional lots will be available in the April - May 2024 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Lidocaine HCl Injection, USP, Injection, 20 mg/1 mL (NDC 0143-9575-10) | Unavailable | Additional lots will be available in the April - May 2024 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Hospira, Inc., a Pfizer Company (Revised 03/28/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 10 mg/1 mL (NDC 0409-9137-05) | Available | ||
Lidocaine Hydrochloride Preservative Free, Injection, 10 mg/1 mL (NDC 0409-4713-32) | Available | ||
Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 0409-4276-01) | Available | ||
Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-4279-02) | Available | ||
Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 0409-4276-02) | Available | ||
Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0409-4282-01) | Available | ||
Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0409-4282-02) | Available | ||
Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-4904-34) | Unavailable | Next Delivery and Estimated Recovery: December 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Demand increase for the drug |
Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0409-4903-34) | Unavailable | Next Delivery: July 2024; Estimated Recovery: June 2025; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay | Demand increase for the drug |
Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0409-2066-05) | Unavailable | Next Delivery: March 2024; Estimated Recovery: June 2024 | Demand increase for the drug |
Lidocaine Hydrochloride In Plastic Container, Injection, 20 mg/1 mL (NDC 0409-4277-01) | Available | ||
Lidocaine Hydrochloride In Plastic Container, Injection, 20 mg/1 mL (NDC 0409-4277-02) | Available | ||
Lidocaine Hydrochloride Preservative Free, Injection, 40 mg/1 mL (NDC 0409-4283-01) | Available | ||
Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 20 mg/1 mL (NDC 0409-1323-05) | Available | ||
Lidocaine Hydrochloride In Plastic Container, Injection, 5 mg/1 mL (NDC 0409-4275-01) | Unavailable | Next Delivery: October 2024; Estimated Recovery: TBD; Shortage per Manufacturer: Manufacturing Delay | Demand increase for the drug |
Lidocaine Hydrochloride, Injection, 5 mg/1 mL (NDC 0409-4278-01) | Available | ||
Lidocaine Hydrochloride Preservative Free, Injection, 10 mg/1 mL (NDC 0409-4713-02) | Available | ||
Lidocaine Hydrochloride Preservative Free, Injection, 15 mg/1 mL (NDC 0409-4776-01) | Available |
Huons Co., Ltd. (South Korea) (Reverified 04/16/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2) | Available |
Sintetica US (Reverified 12/19/2023)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 83090-001-10) | Available | ||
Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 83090-002-10) | Available | ||
Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 83090-003-10) | Available | ||
Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 83090-004-10) | Available | ||
Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 83090-005-10) | Available | ||
Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 83090-006-10) | Available | ||
Lidocaine Hydrochloride, Injection, 40 mg/1 mL (NDC 83090-007-10) | Available |
Spectra Medical Devices, LLC (Reverified 04/01/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Injection, 10 mg/1 mL (NDC 65282-1605-1) | Available |